| Name | N-[(7S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide |
|---|---|
| Synonyms |
Colchicine,10-thio
Thiocolchicine, 10 mM in DMSO breast,LoVo/DX,MDR-positive,Microtubule/Tubulin,inhibit,MCF-7,leukemia,Colchicine,Apoptosis,BALB/3T3,cancer,A-549,LoVo,Thiocolchicine,Analogue,Inhibitor N-[(7S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide Colchicine,10-demethoxy-10-(methylthio) EINECS 220-346-8 Thiocholchicine Thiocolchicoside Impurity B (S)-N-(1,2,3-trimethoxy-10-(methylthio)-9-oxo-5,6,7,9-tetrahydrobenzo[a]htalen-7-yl)acetamide (S)-7-Acetylamino-6,7-dihydro-10-methylthio-1,2,3-trimethoxybenzo[a]htalen-9(5H)-one N-[(S)-5,6,7,9-Tetrahydro-1,2,3-trimethoxy-10-methylthio-9-oxobenzo[a]htalen-7-yl]acetamide thiocolchicine 10-Demethoxy-10-methylthiocolchicine N-((S)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamide N-[(7S)-5,6,7,9-Tetrahydro-1,2,3-triMethoxy-10-(Methylthio)-9-oxobenzo[a]htalen-7-yl]acetaMide thiocholchicine 10-Thiocolchicine Acetamide, N-[(7S)-5,6,7,9-tetrahydro-1,2,3-trimethoxy-10-(methylthio)-9-oxobenzo[a]htalen-7-yl] (S)-7α-Acetylamino-6,7-dihydro-10-(methylthio)-1,2,3-trimethoxybenzo[a]htalene-9(5H)-one N-[(7S,12a)-1,2,3-trimethoxy-10-(methylsulfanyl)-9-oxo-5,6,7,9-tetrahydrobenzo[a]htalen-7-yl]acetamide (thiocolchicine) thiocolhicine N-((S)-1,2,3-Trimethoxy-10-methylmercapto-9-oxo-5,6,7,9-tetrahydro-benzo[a]heptalen-7-yl)-acetamid |
| Description | Thiocolchicine, a derivative modified in the C Ring of Colchicine (HY-16569) with enhanced biological properties. Thiocolchicine is a potent inhibitor of tubulin polymerization (IC50=2.5 µM) and competitively binds to tubulin with a Ki of 0.7 µM. Thiocolchicine induces cell apoptosis[1][2]. Thiocolchicine can be used as an ADC cytotoxin in ADC technology. |
|---|---|
| Related Catalog | |
| In Vitro | Thiocolchicine is against MCF-7, LoVo, LoVo/DX, A-549 and BALB/3T3 cells with IC50 values of 0.01 μM, 0.021 μM, 0.398 μM, 0.011 μM and 0.114 μM, respectively[3]. Thiocolchicine (1 nM-100 μM; 24-72 hours) shows a relationship between cell cycle blocking activity and growth inhibition in breast cancer cells. It inhibits cell proliferation of MDA-MB-231 and multidrug resistant (MDR) MCF-7 ADRr breast cancer cells with IC50s of 0.6 nM and 400 nM, respectively, as well as MDR CEM-VBL leukemia cells (IC50=50 nM)[2]. |
| References |
| Density | 1.27g/cm3 |
|---|---|
| Boiling Point | 729.1ºC at 760mmHg |
| Molecular Formula | C22H25NO5S |
| Molecular Weight | 415.50300 |
| Flash Point | 394.7ºC |
| Exact Mass | 415.14500 |
| PSA | 99.16000 |
| LogP | 3.97580 |
| Vapour Pressure | 4.12E-21mmHg at 25°C |
| Index of Refraction | 1.609 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300 + H330-H318-H340 |
| Precautionary Statements | P201-P260-P264-P280-P284-P301 + P310 |
| Hazard Codes | T+ |
| RIDADR | UN 1544PSN1 6.1 / PGI |
| Precursor 7 | |
|---|---|
| DownStream 7 | |